article · Vaccine
Measles remains a major public health challenge in Ethiopia, with rising incidence in recent years and marked geographic disparities in disease burden and vaccination coverage. Despite improvements in routine immunisation, coverage remains below levels required for elimination, and the introduction of MCV2 has not yet produced a measurable impact. Strengthening routine vaccination, enhancing surveillance quality, and targeting underserved regions are essential to reduce measles transmission and move towards national and global elimination goals.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.vaccine.2026.128524
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
